Use of posaconazole for the treatment of fungal infections

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4196 (2006.01) A61K 31/4178 (2006.01) A61K 31/496 (2006.01) A61P 31/10 (2006.01) C07D 249/00 (2006.01)

Patent

CA 2499897

The use of posaconazole for the preparation of a medicament for the treatment or prevention of fungal infections in humans of 12 years and older in need of such treatment or prevention the medicament which comprises an effective amount of posaconazole in divided doses two to four times a day to produce an arithmetic mean steady state average maximum plasma concentration of posaconazole of at least about 300 ng/mL to at least about 550 ng/mL is disclosed.

L'invention concerne l'utilisation de posaconazole pour la préparation d'un médicament destiné au traitement ou à la prévention d'infections fongiques chez des humains de 12 années et plus nécessitant un tel traitement ou prévention, ce médicament comprenant une quantité effective de posaconazole en doses divisées, correspondant à des prises de deux à quatre doses par jour, afin de produire une concentration plasmatique moyenne d'état stationnaire avec une moyenne arithmétique de posaconazole d'au moins 300 ng/ml environ jusqu'à 550 ng/ml environ.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of posaconazole for the treatment of fungal infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of posaconazole for the treatment of fungal infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of posaconazole for the treatment of fungal infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1649337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.